Page last updated: 2024-08-22

stavudine and Cholera Infantum

stavudine has been researched along with Cholera Infantum in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, U; Kumar, S; Nagpal, M; Tayal, V1
Katzenstein, D1
Chen, J; He, Y; Huang, ZL; Li, H; Liu, C; Liu, M; Ou, QY; Shen, Z; Zheng, YH1

Trials

1 trial(s) available for stavudine and Cholera Infantum

ArticleYear
[Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Zhonghua yi xue za zhi, 2007, Nov-13, Volume: 87, Issue:42

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amylases; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; gamma-Glutamyltransferase; Gastrointestinal Diseases; HIV Infections; HIV-1; Humans; Inosine; Male; Middle Aged; Neuritis; Nevirapine; RNA, Viral; Stavudine; Time Factors; Treatment Outcome; Viral Load

2007

Other Studies

2 other study(ies) available for stavudine and Cholera Infantum

ArticleYear
Adverse drug reactions to antiretroviral therapy in AIDS patients at a tertiary care hospital in India: A prospective observational study.
    Indian journal of medical sciences, 2010, Volume: 64, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Central Nervous System Diseases; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; India; Lamivudine; Male; Medication Adherence; Middle Aged; Nevirapine; Severity of Illness Index; Stavudine; Tertiary Care Centers

2010
The longer the better? Four years of durable, initially boosted protease treatment.
    AIDS (London, England), 2004, Mar-26, Volume: 18, Issue:5

    Topics: Antiretroviral Therapy, Highly Active; Gastrointestinal Diseases; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Lopinavir; Pyrimidinones; Ritonavir; Stavudine; Time Factors; Treatment Failure

2004